Latest Articles
Sad reason Bindi missed TV appearance - News.com.au
Sad reason Bindi missed TV appearance News.com.au
Published: Oct. 29, 2025, 2:13 p.m.
With this unprecedented $5-million gift, one family hopes to bring overdue attention to endometriosis care in Canada - Sinai Health
With this unprecedented $5-million gift, one family hopes to bring overdue attention to endometriosis care in Canada Sinai Health
Published: Oct. 29, 2025, noon
Is RDAGU stock a buy on dips - July 2025 Weekly Recap & Weekly Watchlist of Top Performers - Fundação Cultural do Pará
Is RDAGU stock a buy on dips - July 2025 Weekly Recap & Weekly Watchlist of Top Performers Fundação Cultural do Pará
Published: Oct. 29, 2025, 9:16 a.m.
Period Blood Is the New ‘Frontier’ In Science — And Women’s Health - The Story Exchange
Period Blood Is the New ‘Frontier’ In Science — And Women’s Health The Story Exchange
Published: Oct. 28, 2025, 4:47 p.m.
S01 E05 - Dispelling the myths of a 'lazy girl's diagnosis' | (MIS)Treated - TVO
S01 E05 - Dispelling the myths of a 'lazy girl's diagnosis' | (MIS)Treated TVO
Published: Oct. 28, 2025, 1 p.m.
Pearsanta initiates study of blood test for early endometriosis detection - Medical Device Network
Pearsanta initiates study of blood test for early endometriosis detection Medical Device Network
Published: Oct. 28, 2025, 11:10 a.m.
Pearsanta initiates study of blood test for early endometriosis detection - Yahoo
Pearsanta initiates study of blood test for early endometriosis detection Yahoo
Published: Oct. 28, 2025, 10:05 a.m.
The pain women keep being told to ignore: Why pelvic pain is not always endometriosis - India TV News
The pain women keep being told to ignore: Why pelvic pain is not always endometriosis India TV News
Published: Oct. 28, 2025, 9:50 a.m.
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up - Nature
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up Nature
Published: Oct. 28, 2025, 8:59 a.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace
Published: Oct. 28, 2025, 5:03 a.m.
Link copied to clipboard!